BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34313294)

  • 1. A lipidomic view of SARS-CoV-2.
    Ebrahimi KH; McCullagh JSO
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34313294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting lipid metabolism alterations in SARS-CoV-2.
    Casari I; Manfredi M; Metharom P; Falasca M
    Prog Lipid Res; 2021 Apr; 82():101092. PubMed ID: 33571544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows.
    Mussap M; Fanos V
    Clin Chem Lab Med; 2021 Nov; 59(12):1891-1905. PubMed ID: 34332518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
    Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pathogenic Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Possible Mechanisms for Immune Evasion?
    Wang Z; Zhou M; Fu Z; Zhao L
    Front Immunol; 2021; 12():693579. PubMed ID: 34335604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiomics integration-based molecular characterizations of COVID-19.
    Li CX; Gao J; Zhang Z; Chen L; Li X; Zhou M; Wheelock ÅM
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34864875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Insights into COVID-19 Pathophysiology, Immune Pathogenesis, Detection, and Treatment.
    Rezaei Z; Mobasheri L; Sadri F
    DNA Cell Biol; 2021 Jul; 40(7):858-868. PubMed ID: 33989051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target.
    Abu-Farha M; Thanaraj TA; Qaddoumi MG; Hashem A; Abubaker J; Al-Mulla F
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2-specific virulence factors in COVID-19.
    Kumar A; Prasoon P; Kumari C; Pareek V; Faiq MA; Narayan RK; Kulandhasamy M; Kant K
    J Med Virol; 2021 Mar; 93(3):1343-1350. PubMed ID: 33085084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
    Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
    Front Immunol; 2021; 12():589095. PubMed ID: 33995341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-based therapies against SARS-CoV-2 infection.
    Alketbi EH; Hamdy R; El-Kabalawy A; Juric V; Pignitter M; A Mosa K; Almehdi AM; El-Keblawy AA; Soliman SSM
    Rev Med Virol; 2021 Sep; 31(5):1-13. PubMed ID: 34546604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol 25-hydroxylase expression following immune activation in response to SARS-CoV-2 infection.
    Davidson J; Rotondo D
    Curr Opin Lipidol; 2021 Aug; 32(4):266-267. PubMed ID: 34227577
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure of Nonstructural Protein 1 from SARS-CoV-2.
    Clark LK; Green TJ; Petit CM
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33234675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uneven metabolic and lipidomic profiles in recovered COVID-19 patients as investigated by plasma NMR metabolomics.
    Bizkarguenaga M; Bruzzone C; Gil-Redondo R; SanJuan I; Martin-Ruiz I; Barriales D; Palacios A; Pasco ST; González-Valle B; Laín A; Herrera L; Azkarate A; Vesga MA; Eguizabal C; Anguita J; Embade N; Mato JM; Millet O
    NMR Biomed; 2022 Feb; 35(2):e4637. PubMed ID: 34708437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV2 and pregnancy: An invisible enemy?
    Verma S; Carter EB; Mysorekar IU
    Am J Reprod Immunol; 2020 Nov; 84(5):e13308. PubMed ID: 32678975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs.
    Malone B; Simovski B; Moliné C; Cheng J; Gheorghe M; Fontenelle H; Vardaxis I; Tennøe S; Malmberg JA; Stratford R; Clancy T
    Sci Rep; 2020 Dec; 10(1):22375. PubMed ID: 33361777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis.
    Aggarwal S; Acharjee A; Mukherjee A; Baker MS; Srivastava S
    J Proteome Res; 2021 Feb; 20(2):1107-1132. PubMed ID: 33426872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
    Boumaza A; Gay L; Mezouar S; Bestion E; Diallo AB; Michel M; Desnues B; Raoult D; La Scola B; Halfon P; Vitte J; Olive D; Mege JL
    J Infect Dis; 2021 Aug; 224(3):395-406. PubMed ID: 33493287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection.
    Wang X; Xu G; Liu X; Liu Y; Zhang S; Zhang Z
    Cell Mol Immunol; 2021 Oct; 18(10):2313-2324. PubMed ID: 34471261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.